-
Overview
Date & Location
11/24/2020 - 11/24/2021, 12:00AM CST Online
Overview
This is a conversation with Dr. Ruth Berggren, Professor of Medicine/Infectious Diseases and Director, Center for Medical Humanities and Ethics at º£½ÇÂ×ÂÒ, regarding outpatient management strategies for COVID-19. General recommendations are discussed, as well as the use of monoclonal antibodies and the off-label use of supplements and medications for which there is some preliminary data.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 3
- List equipment recommended for the outpatient with COVID-19
- Discuss the role of monoclonal antibodies in the treatment of COVID-19
- List supplements and mediciations that have shown promise in the preliminary studies for coronavirus infection (off-label use).
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 11/24/2020 Credits expire: 11/24/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
º£½ÇÂ×ÂÒDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, º£½ÇÂ×ÂÒ. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Ruth Berggren, MD, MACP
Professor of Medicine/Infectious Diseases
Joe R. and Teresa Lozano Long School of Medicine
Director, Center for Medical Humanities and Ethics
º£½ÇÂ×ÂÒDr. Berggren is a Professor of Medicine/Infectious Diseases at The Joe R. and Teresa Lozano Long School of Medicine and directs the Center for Medical Humanities & Ethics at º£½ÇÂ×ÂÒ. In this role, she teaches ethics and professionalism while nurturing empathy and humanitarian values. The Center focuses on four areas: ethics and professionalism; global health; community service learning; and the medical humanities (literature, music and art).
Dr. Berggren arrived at º£½ÇÂ×ÂÒ in fall 2006 after an eventful stint at New Orleans’ Charity Hospital, where she stood by her mostly uninsured patients in the HIV ward during Hurricane Katrina until all were safely evacuated six days later. She reflected on the experience in articles published in the New England Journal of Medicine and a commencement address to the Health Science Center School of Medicine. Her determination to inspire humanism in medicine and effect change through her own experiences led to her being named director of the Center for Medical Humanities & Ethics in October 2007.
The daughter of public health physicians, Dr. Berggren spent her childhood at Haiti’s Hôpital Albert Schweitzer, named for the Nobel Prize-winning physician and humanitarian known for his philosophy of reverence for life. During medical school, she was named an Albert Schweitzer Fellow and traveled to the West African nation of Gabon to work at the hospital established by Dr. Schweitzer. Her involvement in global health and ties to Haiti continue today. Following the 2010 earthquake in Haiti, Dr. Berggren was active in relief efforts along the Haitian-Dominican border. She lectured widely on these experiences and on disaster preparedness for the American College of Physicians, Centers for Disease Control, American Medical Association, Pan American Health Organization and medical schools nationwide.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. Ruth Berggren has disclosed that she is a sub-investigator for the Sinai vaccine trial.
